CYCLIN-DEPENDENT KINASE INHIBITOR, PALBOCICLIB – A NEW DRUG FOR THE TREATMENT OF METASTATIC BREAST CANCER by E. N. Imyanitov, T. Yu. Semiglazova

Get full text

Vozmozhnosti primeneniya kselody (kapetsitabina) v lechenii disseminirovannogo raka molochnoy zhelezy, rezistentnogo k antratsiklinovym antibiotikam i taksoteru (dotsetakselu) by M L Gershanovich, T Yu Semiglazova

Get full text

PREVENTION AND MONITORING OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER by N. A. Kozyavin, T. Yu. Semiglazova

Get full text

Clinical end pharmacoeconomic aspects of neoadjuvant therapy of breast cancer by V. A. Kostorov, T. Yu. Semiglazova, A. V. Pavlysh

Get full text

DIAGNOSIS AND PREVENTION OF CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER FROM THE STANDPOINT OF AN ONCOLOGIST AND A CARDIOLOGIST by T. Yu. Semiglazova, G. M. Teletaeva, N. A. Kozyavin, A. V. Zagatina

Get full text

The role of gut microbiota in forming a response to immunotherapy of malignant neoplasms: problem state by T. Yu. Semiglazova, N. A. Brish, T. Yu. Galunova, A. S. Bernatskiy, V. V. Semiglazov

Get full text

Problems of diagnostics and treatment of the epithelial and non-epithelial breast tumors by Van Shu, A. S. Artemieva, E. A. Busco, V. V. Semiglazov, T. Yu. Semiglazova

Get full text

Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer by T. Yu. Semiglazova, V. V. Semiglazov, L. V. Filatova, P. V. Krivorotko, V. V. Kolarkova, V. F. Semiglazov

Get full text

Features of nutritional support during stem cell transplantation by S. A. Volchenkov, L. V. Filatova, E. V. Cherkasova, A. K. Koviazin, S. V. Lyubimov, I. S. Zyuzgin, T. Yu. Semiglazova

Get full text

General St. Gallen-2015 guidelines for the treatment of early breast cancer (adapted by the experts of the Russian Society of Breast Oncologists) by V. F. Semiglazov, R. M. Paltuev, V. V. Semiglazov, G. A. Dashyan, T. Yu. Semiglazova, P. V. Krivorotko, K. S. Nikolaev

Get full text

BCD-100 - first russian PD-1 inhibitor by S A Tyulyandin, M Yu Fedyanin, T Yu Semiglazova, V M Moiseenko, S V Odintsova, B Ya Alekseev, R A Ivanov, M S Shustova

Get full text

Breast cancer biomarker (ER, PR, HER2) changes in the phenotype after neoadjuvant treatment by V. O. Bashlyk, A. G. Kudaibergenova, A. S. Artemyeva, A. L. Muravtseva, V. S. Chirsky, T. Yu. Semiglazova, V. V. Klimenko, V. F. Semiglazov

Get full text

International rehabilitation model for oncological patients by T. Yu. Semiglazova, V. A. Klyuge, B. S. Kasparov, K. O. Kondratyeva, A. A. Krutov, M. A. Zernova, V. A. Chulkova, V. V. Semiglazov

Get full text

The significance of upfront autologous stem cell transplantation for high‐intermediate/high‐risk stage IV diffuse large B‐cell lymphoma by Aleksei K. Koviazin, Larisa V. Filatova, Ilia S. Zyuzgin, Anna S. Artemyeva, Ilia L. Poliatskin, Darya S. Burda, Stanislav A. Volchenkov, Svetlana S. Elkhova, Tatiana Yu. Semiglazova

Get full text

Quality of life is the fundamental criterion of the efficacy of targeted therapy in patients with metastatic Her2-positive breast cancer by T Yu Semiglazova, G A Dashyan, V V Semiglazov, A S Zhabina, M A Osipov, Z S Kotova, V V Klimenko, P V Krivorotko, V F Semiglazov

Get full text

Prognostic impact of immunohistochemical and molecular genetic markers in Diffuse Large B-cell lymphoma by E. V. Kharchenko, T. Yu. Semiglazova, A. S. Artem’yeva, G. S. Kireyeva, I. L. Polyatskin, I. S. Zyuzgin, L. V. Filatova, Yu. A. Chudinovskikh, M. S. Motalkina, Yu. A. Oleynik

Get full text

The illustration of the successful mobilization of hematopoietic stem cells using plerixafor and pegfilgrastim in the patient with non-hodgkin's lymphoma by M S Motalkina, S A Kulyova, S M Alexeev, I S Zuzgin, L V Filatova, A S Zhabina, A A Zverkova, I V Ishmatova, A A Rjazankina, A S Artemyeva, T Yu Semiglazova

Get full text

Correlation of the value of sonoelastography strain ratio with the degree of pathological regression in patients with locally advanced breast cancer undergoing neoadjuvant chemothe... by E. A. Bus’ko, A. V. Mishchenko, V. V. Semiglazov, P. V. Krivorot’ko, T. Yu. Semiglazova, R. M. Paltuev, A. S. Petrova, A. V. Komyakhov, V. F. Semiglazov

Get full text

Efferent therapy in the first-line drug treatment of metastatic colorectal cancer by Z. S. Kotova, T. Yu. Semiglazova, I. A. Baldueva, D. H. Latipova, D. O. Yurlov, V. V. Semiglazov, G. M. Teletaeva, A. V. Novik, A. I. Semenova, S. A. Protsenko

Get full text

The consensus on the prevention and correction of rash in patients with HR+ HER2- metastatic breast cancer treated with alpelisib by Irena L. Shlivko, Oxana E. Garanina, Elena V. Artamonova, Inna P. Ganshina, Liudmila G. Zhukova, Irina A. Koroleva, Anna V. Michenko, Tatiana Yu. Semiglazova, Daria A. Filonenko

Get full text